129 related articles for article (PubMed ID: 38904499)
1. Association between genetic polymorphisms in fibrinogen genes and bleeding risk in patients treated with direct oral anticoagulants.
Choi KH; Yee J; Song TJ; Park J; Gwak HS
Ann Acad Med Singap; 2023 Jul; 52(7):340-347. PubMed ID: 38904499
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study.
Theodoraki EV; Nikopensius T; Suhorutsenko J; Peppes V; Fili P; Kolovou G; Papamikos V; Richter D; Zakopoulos N; Krjutskov K; Metspalu A; Dedoussis GV
BMC Med Genet; 2010 Feb; 11():28. PubMed ID: 20167083
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Aalpha312 and Bbeta448 polymorphisms are not related to bleeding during oral vitamin K-antagonist treatment.
Garcia AA; van der Hoeven NV; Boellaard TN; van der Heijden JF; Groot AP; Reitsma PH
Thromb Haemost; 2007 Apr; 97(4):676-8. PubMed ID: 17393034
[No Abstract] [Full Text] [Related]
5. Genetic polymorphisms influencing total and γ' fibrinogen levels and fibrin clot properties in Africans.
Kotzé RC; Nienaber-Rousseau C; De Lange Z; De Maat MP; Hoekstra T; Pieters M
Br J Haematol; 2015 Jan; 168(1):102-12. PubMed ID: 25156046
[TBL] [Abstract][Full Text] [Related]
6. Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.
Ording AG; Søgaard M; Skjøth F; Grove EL; Lip GYH; Larsen TB; Nielsen PB
Cancer Med; 2021 Jul; 10(13):4405-4414. PubMed ID: 34114733
[TBL] [Abstract][Full Text] [Related]
7. Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation.
Fatima B; Mohan A; Altaie I; Abughosh S
J Manag Care Spec Pharm; 2024 May; 30(5):408-419. PubMed ID: 38701026
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
[TBL] [Abstract][Full Text] [Related]
9. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
[TBL] [Abstract][Full Text] [Related]
10. Relative performance evaluation of four bleeding risk scores in atrial fibrillation patients. What does the new DOAC score provide?
Abu-Assi E; Lizancos Castro A; Cespón-Fernández M; González-Bermúdez I; Raposeiras Roubin S
Int J Cardiol; 2024 Jul; 407():132018. PubMed ID: 38579940
[TBL] [Abstract][Full Text] [Related]
11. Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.
Pruissen DM; Rosendaal FR; Gorter JW; Garcia AA; Kappelle LJ; Algra A;
J Neurol; 2007 Dec; 254(12):1660-5. PubMed ID: 17994314
[TBL] [Abstract][Full Text] [Related]
12. Genetic Factors of Renin-Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants.
Yee J; Song TJ; Yoon HY; Park J; Gwak HS
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213964
[TBL] [Abstract][Full Text] [Related]
13. Direct Oral to Parenteral Anticoagulants: Strategies for Inpatient Transition.
Lopez CN; Succar L; Varnado S; Donahue KR
J Clin Pharmacol; 2021 Jan; 61(1):32-40. PubMed ID: 32639606
[TBL] [Abstract][Full Text] [Related]
14. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding.
Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Frymire E; Khan S; Johnson AP;
Thromb Res; 2019 Oct; 182():12-19. PubMed ID: 31434018
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen gene variation and ischemic stroke.
Jood K; Danielson J; Ladenvall C; Blomstrand C; Jern C
J Thromb Haemost; 2008 Jun; 6(6):897-904. PubMed ID: 18331453
[TBL] [Abstract][Full Text] [Related]
16. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
Chan YH; Lee HF; Chao TF; Wu CT; Chang SH; Yeh YH; See LC; Kuo CT; Chu PH; Wang CL; Lip GYH
Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
[TBL] [Abstract][Full Text] [Related]
17. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
18. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels].
Titov BV; Barsova RM; Martynov MIu; Nikonova AA; Favorov AV; Gusev EI; Favorova OO
Mol Biol (Mosk); 2012; 46(1):93-102. PubMed ID: 22642105
[TBL] [Abstract][Full Text] [Related]
20. [Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)].
Vicente V; Martín A; Lecumberri R; Coll-Vinent B; Suero C; González-Porras JR; Marco P; Mateo J; Roldán V; Soulard S; Crespo C; Camats M;
Emergencias; 2017 Feb; 29(1):18-26. PubMed ID: 28825264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
